T細(xì)胞受體或TCR是在T淋巴細(xì)胞表面上發(fā)現(xiàn)的分子,其負(fù)責(zé)識(shí)別與主要組織相容性復(fù)合體(MHC)分子結(jié)合的抗原。在95%的T細(xì)胞中,它是由α和β鏈組成的異二聚體,而5%的T細(xì)胞具有由γ和δ鏈組成的TCR。TCR與抗原和MHC的接合導(dǎo)致其T淋巴細(xì)胞通過(guò)由相關(guān)酶、共受體和特化輔助分子介導(dǎo)的一系列生化事件活化。 抗小鼠4-1BB(3 H3)體內(nèi)抗體-低內(nèi)毒素該產(chǎn)品同種型對(duì)照:Rat IgG2a In Vivo Isotype Control - Low Endotoxin [1-1] (ICH2244) 緩沖液:ICH3001-100ml,nICH3002-100ml,nICH3003-100ml, 濃度:1.0 - 5.0 mg/ml 純度:>95% by SDS-PAGE and HPLC 內(nèi)毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.
應(yīng)用類型
Western Blot, Functional Assays, ELISA, Stimulation, Immunoprecipitation